|Day Low/High||246.40 / 249.84|
|52 Wk Low/High||184.50 / 301.32|
In highlights from this week's trading diary and posts, Kass discusses a difference between the equity and the fixed-income markets, and watches as the market bends, just a little.
Markets keep surging amid strong earnings and upbeat Fed commentary. In the portfolio, we add to 3 positions and trim 4.
SoftBank's $3.3 billion deal for Fortress topped the notable transactions this week.
Allergan's most-recent quarterly financial report for Q4/2016 showed solid results.
Wall Street smashes records again on Tuesday, closing at all-time highs for its fourth consecutive session.
Wall Street hold small gains on Tuesday after Federal Reserve Chair Janet Yellen plays the part of both dove and hawk.
Wall Street is mixed on Tuesday morning after Federal Reserve Chair Janet Yellen champions the strength of the U.S. economy.
The two will split litigation fees 50-50.
CEO Lew Cirne tells Jim Cramer New Relic is using cloud analytics to help companies gain better insight.
VMware CEO Pat Gelsinger tells Jim Cramer that technology is now touching virtually every aspect of business.
CEO Bryan Krzanich tells Jim Cramer that Intel is always thinking five years into the future.
Jim Cramer's bullish on ZELTIQ Aesthetics, Chesapeake Energy, Priceline Group and more.
Jim Cramer says it's a sea change: It's not just about economic growth, it's about global growth without inflation.
The good vibes that carried Wall Street to new records last week lingered on into Monday's session.
The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.
Buying Zeltiq Aesthetics expands position in body contouring.
Here's how to trade seven of the most active names on the market.
Allergan shares are rising on news the company is purchasing medical tech company Zeltiq Aesthetics for roughly $2.5 billion.
Stocks trade above record highs set on Friday as good vibes over the potential Trump tax reform plan are sustained over the weekend.
Allergan is buying body-sculptor Zeltiq. CEO Brent Saunders deems it to be the Botox of 10 years ago and he expects the deal to be immediately accretive.
Stocks edge higher on Monday as good vibes from Friday's record-breaking rally are sustained through the weekend.
Stock futures edge higher on Monday morning as good vibes from Friday's record-breaking rally are sustained through the weekend.
- Immediately Accretive All Cash Transaction Expected to Close in the Second Half of 2017 -
Jim Cramer ponders what makes people dump good stocks and discusses the ride gamers, oil and industrials took.
Earnings and talk of the administration's tax plan invigorate markets. We add 2 positions to the portfolio and drop an energy name.
Amazon, J&J, IBM and others don't deserve this treatment.